Adaptive Self Injection Systems


adaptive self injection systems   Adaptive Self Injection Systems •  December 2017 •  US $2,850



 

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as specialty syringes and specialized injection devices proliferate in response to safety and formulation challenges posed by new and emerging drugs, and as the administration of injectables moves increasingly from practitioner offices and healthcare facilities to patient homes. In response to these market dynamics, device suppliers are introducing injection systems that possess new capabilities and which can adapt to the evolving needs of drug developers and patients. This report analyzes more than two dozen adaptive devices currently being marketed for patient use.

Bar_Graph Adaptive Self Injection Report Brochure (Download PDF)

Blue document Adaptive Self Injection Report Order Form (Download PDF)

  Click here to Order Online

 


Adaptive Self Injection Systems – What You Will Learn

• What injection devices intended for self administration incorporate adaptive features and/or functionality?? What are their operational characteristics?
• What therapeutic drug markets are driving demand for adaptive self injection devices?
• Who are the important adaptive feature/functionality self injection system suppliers, their capabilities, and their business strategies?
• What are the major factors driving adaptive injection device demand?
• How important are drug developer-device manufacturer/ecosystem relationships in this sector and what are the key alliances in the industry?
• How are the current generation of adaptive feature/functionality injection devices aligned with various drug classes and therapeutic markets?
• What size is the market today? What will it be in 2024?
• What are the significant economic, technology, and regulatory factors affecting this market?


Adaptive Self Injection Systems – Summary of Contents

Executive Summary

Injectable Device Evolution

Drug Development Trends
Drug Formulation Diversity
The Device Design Envelope
Converging Device Requirements
Adaptability & Ergonomics
Device Selection Factors
Competitive Landscape

Device Design Factors

Market Segmentation
Device Feature Requirements
Materials Selection
Patient Interface
Injection Methodology
Product Specific Devices
Patient Population Variability

Injectable Drug Market Dynamics

Market Demand Drivers
Diseases & Indications
The Patient Experience

Self-Administration Device Classes
Handheld Injection Systems
Autoinjectors
Disposable Autoinjectors
Reusable Autoinjectors
Small Form Factor Autoinjectors
Dual Chamber Injectors
Needle-free Injectors
Pen Injectors
Disposable Pens
Reusable Pens
Wearable Injection Systems
Large Volume (< 2 mL) Injectors
Patch-like Injectors
Subcutaneous Infusion Devices

Adaptable Injectors – Feature Sets

Low-volume/High Frequency
Variable Dosing
Push-on-Skin Autoinjectors
Injection Confirmation
Custom Injection Rates
Needle Insertion Speed/Depth
Patient Prompts/Guidance
One-step Reconstitution
Wireless Connectivity
High Volume Dosing
High Viscosity Dosing
Duration Dependent Dosing

Adaptable Injection System Product
Assessments & Market Data

Adaptive Dosing & Administration
Injection Event Customization
Ease of Use & Patient Feedback
Point-of-Care Reconstitution
Non-Customary Dose Parameters

Therapeutic Segment Alignment,
Use Cases & Product Forecasts

Anticoagulants
Antivirals
Autoimmune Diseases
Diabetes
Emergency Medicine
Hematopoietics
Hormone Replacement
Neurology
Osteoporosis
Reproductive Health

Market Factors

Regulatory Issues
Device Branding
Patient Compliance and Ease of Use
Healthcare Economics

Company Profiles